On Tuesday, the Colorado Department of Public Health and Environment received results of water sampling in Alamosa performed by the U.S. Centers for Disease Control and Prevention (CDC). The results showed the presence of Giardia and Cryptosporidium, two parasites that also can cause diarrheal illness. These samples were drawn by CDC before the water system was flushed and disinfected. More sampling is needed to confirm that the parasites have been eliminated. New water samples were taken Wednesday by the state’s Water Quality Control Division. Once testing shows the water is suitable for drinking, the state’s boil order will be lifted. But lab results are not expected on the latest samples until sometime this weekend at the earliest. As of Tuesday afternoon, there were 389 total cases of salmonella, with 107 of these culture-confirmed and 16 hospitalized.
2 Parasites Found in Alamosa Water
Thursday, April 10, 2008
2 Parasites Found in Colorado Water
Pre Market Trader Talk with Bob Pisani - CNBC.com
The dollar is weak again; Band of England lowered rates, but Europe has been weak right from the open and that weakness has spilled over into our futures.
Elsewhere:
1) March retail sales were again fairly sluggish, one third beat estimates, two third missed, according to RetailMetrics. A couple standouts: discounters like Wal-Mart [WMT 54.14 --- UNCH (0%) 
], Costco [COST 66.03 --- UNCH (0%) ], BJ's [BJ 35.33 --- UNCH (0%) ] , all did well, so we are clearly seeing tradedown. Teen apparel store Buckle sales were a big surprise up 20.9 percent (up 7 percent expected), Aeropostale [ARO 26.16 --- UNCH (0%) ] also slightly better than expected. The good news is that comps will be easier for next month, because April last year did not include Easter. Rebate checks will not arrive until May.
Wal-Mart's same store sales for March were up 0.7 percent from a year earlier, below expectations of a 1 percent gain. However, they boosted guidance for the first quarter to $074 to $0.76, from $070 to $0.74, so it's up fractionally pre-open.
Men's Wearhouse [MW 22.03 --- UNCH (0%) ]reaffirmed their first quarter estimates of $0.20 to $0.24 (analyst estimate $0.22).
2) DuPont [DD 49.04 --- UNCH (0%) ] raised first quarter and full year guidance. The agricultural business has been particularly strong (about 25 percent of sales), and overall sales in emerging markets has been strong (Asia/Pacific about 20 percent of sales).
3) Lehman [LEH 40.54 --- UNCH (0%) ] has liquidated three investment funds that dropped notably in value and took $1 b of those assets onto its balance sheet. Down 3 percent. Most traders think they are basically bailing out investors hoping the parent can better fund those assets.
More important is Deutsche Bank's Mike Mayo, who met with Lehman's CFO and put out a widely-discussed note this morning. Mayo said his meeting was somewhat downbeat and sober: "Conditions remain tough, whether it relates to client flows, activity, or even hedging." He concluded by saying "Lehman's strategy is evolving to take on less risk to better hunker down in tough times and to generate lower risk earnings growth longer-term. This new harsh reality is sobering to those looking for a quick fix for the financial sector."
Pre Market - Trader Talk with Bob Pisani - CNBC.com
Pre Market Trading Indications
Gapping up in reaction to strong earnings/guidance/same store sales: GPRE +19.2%, APOG +12.8%, FCSX +11.1%, CBK +10.7%, LOOK +9.8%, PIR +8.9%, MW +6.2%, HOTT +4.5%, CHT +2.9%, SMRT +2.4%, CACH +2.3%, LNDC +1.8%, CTR +1.4%, WTSLA +1.2%, IUSA +1.2%, ZUMZ +1.1%...
M&A news: MLNM +51.1% (to be acquired by Takeda Pharma for $25/share in all cash tender offer)...
Other news: FRPT +8.7% (US DOD approves $125 mln armored truck sale to Britain armored truck sale to Britain - Reuters), ABAT +5.0% (announces $3.3 mln contract with Beijing's Ding Xin Yi Tong Science & Technology), GERN +4.4% (FDA hearings on stem-cell drugs - WSJ), AMGN +4.0% (Roche filed on Wednesday to appeal a preliminary court injunction barring U.S. sales of its anemia drug Mircera -- analysts believe the Appeals court will be less likely to allow Roche to launch under a license agreement; also the action date for FDA's priority review of romiplostim has been extended to July 23, 2008), FRO +3.9% (still checking), NKTR +3.7% (announces that "positive preclinical and clinical results" for its pipeline programs will be presented at numerous medical and scientific meetings over the coming months), TX +3.7% (comments on recent developments in Venezuela), CPST +3.7% (announces that it has received an order valued at $2.03 mln from Samsung C&T), HOKU +2.9% (subsidiary Hoku Materials announces amendments to polysilicon plant engineering and construction contracts), CALM +2.7% (announced it will commence new dividend policy for third quarter of fiscal 2008), AMR +2.5% (modestly rebounding; cancels more flights - AP), CTCM +2.4% (Cramer makes positive comments on MadMoney), YHOO +2.1% (News Corp., AOL pursue Yahoo deals - WSJ), EMKR +2.0% (to acquire Intel's enterprise and storage optical assets, intel connects cables business, expects to be accretive to earnings), MRK +1.6% (Cramer makes positive comments on MadMoney), IMCL +1.5% (profiled in Weekday Trader section of Barron's), SHPGY +1.4% (still checking)...
Analyst upgrades: ADCT +6.5% (upgraded to Buy at Deutsche Bank), PMCS +3.1% (upgraded to Neutral at BofA), ARUN +2.3% (upgraded to Buy at Brean Murray), WLK +2.2% (upgraded to Overwt at Morgan Stanley), HAL +1.6% (upgraded to Buy at tier 1 firm), SMTC +1.3% (upgraded to Buy at BofA), ADI +1.3% (upgraded to Buy at BofA), ISRG +1.1% (initiated with a Buy at Lazard).
Pre Market Gap Trading Indications
Gapping up:
MLNM +51.1%, FRPT +18.6%, APOG +12.8%, LOOK +9.8%, CBK +8.7%, MW +5.8%, HOTT +4.5%, FRO +3.9%, TX +3.7%, AMR +2.5%, CTCM +2.4%, SMRT +2.4%, YHOO +2.1%, SHPGY +2.1%, MRK +2.0%, TWX +1.7%, HOKU +1.3%, IUSA +1.2%...
Gapping down:
SMCI -10.8%, VMED -8.9%, FMCN -4.0%, BBBY -3.8%, RAD -3.3%, BCS -3.1%, LEH -2.8%, TS -2.5%, WDFC -2.2%, ERIC -1.5%, RDC -1.3%, UBS -1.0%, VMED -1.0%.
NYSE Arca Morning Update
NYSE Arca Morning Update for Thursday, Apr 10, 2008 :
Stocks trading on NYSE Arca at a price more than 15% away from the previous trade day's consolidated close price. (As of 08:30:00 ET)
Stock | Wednesday's Close | Current Price | Pct Chng | Current NYSE Arca Vol |
|---|---|---|---|---|
MLNM | $16.36 | $24.60 | 50% | 3,003,295 |
10 Most Active stocks on NYSE Arca as of 08:30:00 ET
| Based on Dollar Volume: | Based on Share Volume: | ||||||||||||||||||||||||||||||||||||||||||||
|
|
NYSE Arca Morning Update
Pre-Market Most Active Stocks - NASDAQ Premarket
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pre-Market Most Active Stocks - NASDAQ Premarket
